Transitioning Neovascular Age Related Macular Degeneration Patients to Aflibercept Following an Initial Treat And Extend Dosing Regimen: 18 Month Results

被引：0
|
作者：
Homer, Natalie [1 ]
Grewal, Dilraj Singh [1 ]
Lyon, Alice T. [1 ]
Mirza, Rukhsana [1 ]
Gill, Manjot [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Ophthalmol, Chicago, IL 60611 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 552 imaging methods (CT; FA; ICG; MRI; OCT; RTA; SLO ultrasound); 453 choroid: neovascularization;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3975
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    N Homer
    D S Grewal
    R G Mirza
    A T Lyon
    M K Gill
    Eye, 2015, 29 : 1152 - 1155
  • [2] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    Homer, N.
    Grewal, D. S.
    Mirza, R. G.
    Lyon, A. T.
    Gill, M. K.
    EYE, 2015, 29 (09) : 1152 - 1155
  • [3] Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’
    V P Dave
    Eye, 2015, 29 : 1630 - 1630
  • [4] Response to: ‘Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’
    N Homer
    D S Grewal
    R G Mirza
    A T Lyon
    M K Gill
    Eye, 2015, 29 : 1630 - 1631
  • [5] Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'
    Homer, N.
    Grewal, D. S.
    Mirza, R. G.
    Lyon, A. T.
    Gill, M. K.
    EYE, 2015, 29 (12) : 1630 - 1631
  • [6] Twelve Month Outcomes of Treat and Extend Aflibercept Therapy for Neovascular Age- Related Macular Degeneration
    Barthelmes, Daniel
    Vuong Nguyen
    Arnold, Jennifer
    McAllister, Ian
    Guymer, Robyn
    Essex, Rohan
    Gillies, Mark
    OPHTHALMOLOGICA, 2016, 236 : 16 - 16
  • [7] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
  • [8] Two year results of intravitreal aflibercept injections for neovascular age-related macular degeneration using a treat and extend regimen
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Hosogi, Mika
    Doi, Shinichiro
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Three-year outcomes of a treat and extend regimen of aflibercept for neovascular age-related macular degeneration
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Hirano, Masayuki
    Doi, Shinichiro
    Toshima, Shinji
    Takahashi, Kosuke
    Fujiwara, Atsushi
    Kanzaki, Yuki
    Hosogi, Mika
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] Twelve-Month Outcomes of "Treat and Extend" aflibercept Therapy for Neovascular Age-Related Macular Degeneration
    Barthelmes, Daniel
    Vuong Nguyen
    Arnold, Jennifer
    McAllister, Ian
    Guymer, Robyn
    Essex, Rohan
    Young, Stephanie
    Gillies, Mark C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12345